Cleaning-Disinfection-Sterilization-Storage Of The Suction Rings - MORIA 65005 Manuel Utilisateur

9.5 CLEANING-DISINFECTION-STERILIZATION-STORAGE OF THE SUCTION RINGS

Steps What to do
1 Double cleaning
• On leaving the operating theatre, immediately
immerse the devices in an aldehyde-free
detergent/disinfectant solution (e.g.: Alkazyme
Alkapharm Laboratories) for at least 15 minutes
according to manufacturer recommendations.
• Manual cleaning (or use a machine, provided
that it does not recycle the cleaning products,
after disassembling the device where
appropriate).
• Rinse the circuit with water.
• Immerse the device in an aldehyde-free
detergent/disinfectant solution (a different bath
from the one above).
• Manual cleaning (or use a machine, provided
that it does not recycle the cleaning products).
• Rinse using filtered distilled or osmosis-treated
water.
• Wipe the device using a non-woven, lint-free,
disposable cloth.
2 Deactivation of NCTAs (Non-Conventional
Transmitted Agents)
3 Sterilisation
Sterilise the sterilisation tray using an autoclave
(moist heat steriliser) at a temperature of at least
134°C for 18 minutes.
Sterilization in USA only : sterilize with an
autoclave (steam sterilizer with a vacuum phase) at
a minimum of 132°C for at least 4 minutes.
Bibliography:
• December 2011 – Instruction no. DGS/RI3/2011/449 of 1st December 2011 updating recommendations
aimed at reducing the risk of transmitting non-conventional transmissible agents during invasive
procedures.
• November 2005 - Guide from the Ministry on the treatment of medical devices for ophthalmology and
contactology - http://www.sante.gouv.fr.
IMPORTANT WARNINGS
• Manual cleaning: mechanical cleaning of the
medical device using soft brushes (metal
brushes and scouring pads are prohibited).
/ • IMPORTANT: Change the baths after each use.
®
• Incompatibility:
o Do not use bleach
o Do not apply this protocol to products
made of aluminium alloy.
o Do not apply this protocol to heat-sensitive
(motor and turbine).
• Deactivation of NCTAs: for patients with a risk
of Creutzfeldt-Jakob disease only
• For France, see instruction no. DGS/
RI3/2011/449 of 1st December 2011.
#65005-F-02.2017
13
MORIA